faithful Arthrix Joint Relief chronic

starting up Arthrix Joint Relief become old
 
Photo :Arthrix Joint Relief

further Arthrix Joint Relief Generic Name: toxicodendron pubescens leaf tablet Dosage Form: FOR ANIMAL USE ONLY Print this page Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here. Arthrix Joint Relief ACTIVE INGREDIENTS: Rhus toxicodendron 6X. INDICATIONS: For temporary relief of joint pain. WARNINGS: For pets. Keep out of the reach of children. If symptoms persist consult your veterinarian. If animal is pregnant or nursing, ask a veterinarian before use. Do not use if tamper evident seal around the neck of the bottle is broken or missing. INACTIVE INGREDIENTS: Lactose, Magnesium stearate, Microcrystalline cellulose. Distributed by: ZHOLISTICS, Iowa City, IA 52245 888-558-1783 www.zholistics.com Arthrix Joint Relief FOR PETS HOMEOPATHIC 125 TABLETS Arthrix Joint Relief thus toxicodendron, tablet Product Information Product Type OTC ANIMAL DRUG Item Code (Source) NDC:57520-0240 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TOXICODENDRON PUBESCENS LEAF (TOXICODENDRON PUBESCENS LEAF) TOXICODENDRON PUBESCENS LEAF 6 [hp_X] in 1 mg Inactive Ingredients Ingredient Name Strength LACTOSE MAGNESIUM STEARATE CELLULOSE, MICROCRYSTALLINE Product Characteristics Color white (white) Score no score Shape ROUND (round convex) Size 6mm Flavor Imprint Code diamond Contains Packaging # Item Code Package Description 1 NDC:57520-0240-1 15000 mg in 1 BOTTLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved homeopathic 11/03/2010 Labeler - Apotheca Company (844330915) Establishment Name Address ID/FEI Operations Apotheca Company 844330915 manufacture Revised: 11/2010 Apotheca Company FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More to intensify


humorist Arthrix Joint Relief customise


EmoticonEmoticon